Porous film

A porous membrane with a hydrophobic and hydrophilic polymer blend and a gradient structure addresses the challenge of high throughput and effective virus removal, enhancing filtration efficiency and protein recovery in antibody-containing liquids.

JP2024168853APending Publication Date: 2024-12-05ASAHI KASEI MEDICAL CO LTD
View PDF 11 Cites 0 Cited by

Patent Information

Application Number
JP2023085866
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-25
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Existing virus removal membranes face challenges in achieving high filtration throughput for antibody-containing liquids while maintaining effective virus removal performance, particularly due to hydrophobic interactions and issues with protein blockage, and they are not suitable for efficiently recovering proteins like albumin and globulin.

Method used

A porous membrane composed of a hydrophobic polymer and a hydrophilic polymer with a predetermined structure, featuring a porosity of 35% to 45% and a major axis/minor axis ratio of 1.00 to 1.45 in the dense layer, and a gradient structure with a pore diameter change from the outer surface to the inner surface, optimized to minimize pore deformation and enhance filtration efficiency.

Benefits of technology

The membrane achieves high filtration throughput for antibody-containing liquids and excellent virus removal performance, with a target clearance improvement and reduced protein recovery loss, while suppressing flux decline over time.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024168853000002
    Figure 2024168853000002
  • Figure 2024168853000001
    Figure 2024168853000001
Patent Text Reader

Abstract

To provide a porous film that can highly filtrate antibody-containing liquid against hydrophobic interaction of an antibody and is excellent in virus removal performance.SOLUTION: A porous film contains a hydrophobic polymer and a hydrophilic polymer. A void ratio in a dense layer in the vicinity of an outer surface of the porous film is 35% or more and 45% or less, a long diameter / a short diameter of a hole circumscribed rectangle in the dense layer in the vicinity of the outer surface is 1.00 or more and 1.45 or less, a thickness of the dense layer is 1-8 μm, and a solution with a temperature of 25°C adjusted using a buffer solution so that a concentration of an antibody becomes 15 mg / mL is filtered by the porous film for three hours at effective filtration pressure of 196 kPa. When hydrophobic interaction of an antibody is defined as A and an amount of filtrated antibody-containing liquid is defined as B, the porous film satisfies a relational expression of B=-62.59A+84.68±2.5 (1.01≤A≤1.25).SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a porous membrane. [Background technology]

[0002] In recent years, the use of plasma fraction preparations and biopharmaceuticals as pharmaceuticals has become more widespread due to their low side effects and high therapeutic efficacy. However, because plasma fraction preparations are derived from human blood and biopharmaceuticals are derived from animal cells, there is a risk that pathogenic substances such as viruses may be mixed into the pharmaceuticals.

[0003] In order to prevent viral contamination of pharmaceuticals, the removal or inactivation of viruses is always performed. Methods for removing or inactivating viruses include heat treatment, optical treatment, and chemical treatment. Due to problems such as protein denaturation, virus inactivation efficiency, and chemical contamination, a membrane filtration method that is effective against all viruses regardless of the thermal and chemical properties of the viruses has attracted attention.

[0004] Viruses to be removed or inactivated include polioviruses with a diameter of 25 to 30 nm, the smallest virus being parvoviruses with a diameter of 18 to 24 nm, and relatively large viruses such as HIV viruses with a diameter of 80 to 100 nm. In recent years, there has been an increasing need to remove small viruses such as parvoviruses.

[0005] The primary performance required for a virus removal membrane is safety, including the safety of preventing the plasma fraction preparations and biopharmaceuticals from being contaminated by pathogenic substances such as viruses, and the safety of preventing the introduction of foreign matter such as eluates from the virus removal membrane. For safety reasons, it is important to sufficiently remove viruses using a virus removal membrane to prevent contamination with pathogenic substances such as viruses. Non-Patent Document 1 states that the target clearance value (LRV) for minute virus of mice and porcine parvovirus is 4. Furthermore, to ensure safety by preventing the inclusion of foreign matter such as eluted matter, it is important that no eluted matter is released from the virus removal membrane.

[0006] The second performance required for a virus removal membrane is productivity. Productivity refers to the efficient recovery of proteins such as albumin with a size of 5 nm and globulin with a size of 10 nm. Ultrafiltration membranes and hemodialysis membranes with pore sizes of about several nm, as well as reverse osmosis membranes with even smaller pore sizes, are not suitable as virus removal membranes because proteins clog the pores during filtration. In particular, when the purpose is to remove small viruses such as parvovirus, it has been difficult to achieve both safety and productivity because the size of the virus and the size of the protein are close.

[0007] Patent Document 1 discloses a method for removing viruses using a membrane made of regenerated cellulose. Patent Document 2 discloses a virus removal membrane in which the surface of a membrane made of polyvinylidene fluoride (PVDF) formed by a thermally induced phase separation method is hydrophilized by a graft polymerization method. These membranes tend to have an overwhelmingly low filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody.

[0008] Patent Document 3 discloses a virus removal membrane having an initial virus logarithmic removal rate (LRV) of at least 4.0 against PhiX174, and a surface coated with hydroxyalkyl cellulose. The membrane has a surface made hydrophilic with hydroxyalkyl cellulose, and has a capacity of about 1000 L / m 2 The present invention relates to an essentially hydrophobic polymeric membrane substrate having a throughput of greater than 100 .mu.m.

[0009] Patent Document 4 discloses a virus removal membrane formed from a blend of a polysulfone-based polymer and polyvinylpyrrolidone (PVP). Patent Document 5 discloses a virus removal membrane in which a membrane formed from a blend of a polysulfone polymer and a copolymer of vinylpyrrolidone and vinyl acetate is coated with a polysaccharide or a polysaccharide derivative. These membranes can efficiently separate and remove viruses contained in a solution, and at the same time, allow useful substances to be recovered, such as proteins, to efficiently permeate through them.

[0010] Patent Document 6 discloses a hollow fiber membrane made of polyethersulfone as a base material and a hydrophilic polymer as a coating layer, which can highly efficiently remove viruses contained in a protein solution, achieve a high flux, and suppress a decrease in flux due to clogging during filtration, thereby enabling highly efficient recovery of proteins from a virus-containing protein solution. Patent Document 7 discloses a hollow fiber filtration membrane that contains a polysulfone polymer and a hydrophilic polymer and has a gradient structure in which the pore size increases from the outer surface part of the membrane toward the inner surface part. Even in the presence of relatively small impurities such as protein aggregates that are close in size to the permeating active ingredient, the decrease in flux over time during filtration is suppressed, and the useful ingredient can be efficiently recovered. Patent Document 8 discloses a hollow fiber filtration membrane that contains a polysulfone polymer and a hydrophilic polymer and has an inclined asymmetric structure in which the average pore size of the pores increases from the outer surface to the inner surface. The membrane suppresses the adsorption of proteins to the pore surface of the dense layer during filtration of a protein solution, and has excellent protein permeability. Patent Document 9 discloses a porous membrane with a gradient structure in which the average pore size of pores containing a hydrophobic polymer and a water-insoluble hydrophilic polymer increases from the downstream filtration site to the upstream filtration site. It is possible to recover useful components with high efficiency while suppressing clogging during filtration of a protein solution. Patent Document 10 discloses a porous hollow fiber membrane that contains a polysulfone-based polymer and a hydrophilic polymer and has a dense layer in the center region of the membrane thickness. It is possible to remove viruses while suppressing the flux decrease over time during filtration of a protein solution. Patent Document 11 discloses a porous membrane in which a hydrophilic polymer is coated on a hydrophobic polymer whose surface is defined by TOF-SIMS. It is possible to reduce the phenomenon in which the membranes stick to each other during the production of the porous membrane.

[0011] Patent documents 3 to 11 disclose that membranes containing hydrophobic and hydrophilic polymers are excellent in removing viruses from protein solutions. However, there is no description of these membranes having a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of antibodies. Furthermore, there is no description of these membranes being easy to fabricate into membrane bundles consisting of membranes formed into hollow fiber membranes or tubular membranes. [Prior art documents] [Patent documents]

[0012] [Patent Document 1] Patent No. 4024041 [Patent Document 2] International Publication No. 2004 / 035180 [Patent Document 3] Patent No. 4504963 [Patent Document 4] International Publication No. 2011 / 111679 [Patent Document 5] Patent No. 5403444 [Patent Document 6] Patent No. 6770807 [Patent Document 7] Patent No. 6522001 [Patent Document 8] Patent No. 6433513 [Patent Document 9] Patent No. 6385444 [Patent Document 10] Patent No. 6367977 [Patent Document 11] Patent No. 7185766 [Non-Patent Document 1] PDA Journal of GMP and Validation in Japan, Vol.7, No.1, p.44(2005) Summary of the Invention [Problem to be solved by the invention]

[0013] An object of the present invention is to provide a porous membrane that has a high filtration throughput of an antibody-containing liquid due to hydrophobic interactions of the antibody and has excellent virus removal performance. [Means for solving the problem]

[0014] As a result of intensive research and repeated experiments to solve the above problems, the present inventors discovered that a porous membrane having a specified structure can solve the above problems, and thus completed the present invention.

[0015] That is, the present invention is as follows. [1] A porous membrane containing a hydrophobic polymer and a hydrophilic polymer, The porosity of the dense layer near the outer surface is 35% or more and 45% or less, the ratio of the major axis to the minor axis of the circumscribing rectangle of the hole in the dense layer near the outer surface is 1.00 or more and 1.45 or less; The thickness of the dense layer is 1 to 8 μm, A solution adjusted to an antibody concentration of 15 mg / mL with a buffer solution at 25°C is filtered through the porous membrane at an effective filtration pressure of 196 kPa for 3 hours, and the porous membrane satisfies the relationship B = -62.59A + 84.68 ± 2.5 (1.01≦A≦1.25), where A is the hydrophobic interaction of the antibody and B is the amount of the antibody-containing solution that is filtered. [2] The porous membrane according to [1], wherein the hydrophilic polymer is an electrically neutral, water-insoluble hydrophilic polymer. [3] The porous membrane according to [1] or [2], wherein the hydrophobic polymer is a polysulfone-based polymer. [4] The porous membrane according to [2] or [3], wherein the water-insoluble hydrophilic polymer is a vinyl polymer. [5] The porous membrane according to any one of [1] to [4], wherein the porous membrane has a gradient structure in which the pore size changes continuously from the outer surface of the porous membrane toward the liquid-contacting surface. [6] The porous membrane according to any one of [1] to [5], wherein a gradient index of average pore size from the dense layer to the coarse layer is 0.5 to 12.0. [7] The porous membrane according to any one of [1] to [5], which is an ultrafiltration membrane. [8] The porous membrane according to any one of [1] to [6], which is a virus removal membrane. [9] The porous membrane according to any one of [1] to [7], which is a hollow fiber membrane or a tubular membrane.

[10] A filter comprising the porous membrane according to any one of [1] to [9]. Effect of the Invention

[0016] According to the present invention, it is possible to provide a porous membrane that has a high filtration throughput of an antibody-containing liquid due to hydrophobic interactions of the antibody and has excellent virus removal performance. [Brief description of the drawings]

[0017] [Figure 1] 1 shows a rectangle circumscribing a hole near the outer surface of a porous membrane. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0018] Hereinafter, an embodiment of the present invention will be described in detail. Note that the following is an example for explaining the present invention, and is not intended to limit the present invention to the following content. The present invention can be practiced by appropriately modifying it within the scope of its gist.

[0019] The porous membrane of the present invention is characterized in that the porosity of the dense layer near the outer surface is 35% or more and 45% or less, the long axis / short axis ratio of the circumscribed rectangle of a hole in the dense layer near the outer surface is 1.00 or more and 1.45 or less, the dense layer has a thickness of 1 to 8 μm, and when a solution at 25° C. adjusted with a buffer solution to give an antibody concentration of 15 mg / mL is filtered through the porous membrane at an effective filtration pressure of 196 kPa for 3 hours, where A is the hydrophobic interaction of the antibody and B is the amount of the filtration process of the antibody-containing solution, the porous membrane satisfies the relationship B=-62.59A+84.68±2.5 (1.01≦A≦1.25). By being equal to or less than the upper limit of the formula (B=-62.59A+84.68+2.5), the target clearance rate (LRV) of the virus tends to be improved, while by being equal to or more than the lower limit of the formula (B=-62.59A+84.68-2.5), the filtration throughput of the antibody-containing liquid due to the hydrophobic interaction of the antibody tends to be improved.

[0020] [Composition of porous membrane] The porous membrane of the present invention (hereinafter, simply referred to as "membrane") is composed mainly of hydrophobic polymers and hydrophilic polymers. Here, "composed mainly of hydrophobic polymers and hydrophilic polymers" means that the total of the hydrophobic polymers and the hydrophilic polymers accounts for 80% by mass or more of the materials constituting the porous membrane, preferably 90% by mass or more, more preferably 95% by mass or more, and even more preferably 100% by mass.

[0021] [Hydrophobic polymer] Examples of hydrophobic polymers include polysulfone-based polymers, polyamides, polyimides, polyetherimides, polyphenylene ethers, polyphenylene sulfides, etc., and among these, aromatic polysulfone-based polymers are preferred. Examples of aromatic polysulfone-based polymers used in the present invention include those having a repeating unit represented by the following general formula (1) or general formula (2). In the formula, Ar preferably represents a disubstituted phenyl group, more preferably a disubstituted phenyl group at the para position. The degree of polymerization and molecular weight of the hydrophobic polymer compound are not particularly limited. -O-Ar-C(CH 3 )2 -Ar-O-Ar-SO 2 -Ar-(1) -O-Ar-SO 2 -Ar- (2) The aromatic polysulfone-based polymer may contain a functional group or a substituent such as an alkyl group in the structure of general formula (1) or general formula (2), and the hydrogen atom of the hydrocarbon skeleton may be substituted with another atom or a substituent such as a halogen. The polysulfone-based polymer may be used alone or in combination of two or more kinds.

[0022] [Hydrophilic polymer] In this embodiment, a hydrophilic polymer is one that produces a contact angle of 90 degrees or less when PBS (9.6 g of Dulbecco's PBS(-) powder "Nissui" commercially available from Nissui Pharmaceutical Co., Ltd. is dissolved in water to make a total volume of 1 L) is brought into contact with a polymer film. In this embodiment, the contact angle of the hydrophilic polymer is preferably 60 degrees or less, and more preferably 40 degrees or less. When the hydrophilic polymer having a contact angle of 60 degrees or less is contained, the porous membrane is easily wetted by water, and when the hydrophilic polymer having a contact angle of 40 degrees or less is contained, the tendency to be easily wetted by water is even more remarkable. The contact angle means the angle that a water droplet makes with the surface of a film when the water droplet is dropped on the film surface, and is defined in JIS R3257.

[0023] [Water-insoluble hydrophilic polymer] In this embodiment, the water-insoluble hydrophilic polymer is a substance that satisfies the above contact angle and dissolution rate. In addition to the hydrophilic polymer that is itself water-insoluble, the water-insoluble hydrophilic polymer also includes a water-soluble hydrophilic polymer that is made water-insoluble in the manufacturing process. That is, even if the water-soluble hydrophilic polymer is a substance that satisfies the above contact angle, and is made water-insoluble in the manufacturing process, so that the above dissolution rate is satisfied in the constant pressure dead-end filtration after the filter is assembled, it is included in the water-insoluble hydrophilic polymer in this embodiment.

[0024] The porous membrane of the present embodiment preferably contains a water-insoluble hydrophilic polymer. In order to prevent a sudden decrease in filtration rate due to clogging of the membrane caused by protein adsorption, it is preferable that the porous membrane of this embodiment is hydrophilized by the presence of a water-insoluble hydrophilic polymer on the pore surface of the base membrane containing a hydrophobic polymer. Methods for hydrophilizing the base film include coating, graft reaction, crosslinking reaction, etc., after the base film is formed from a hydrophobic polymer. In addition, after the blend of a hydrophobic polymer and a hydrophilic polymer is formed, the base film may be hydrophilized by coating, graft reaction, crosslinking reaction, etc.

[0025] [Vinyl polymer] An example of the water-insoluble hydrophilic polymer is a vinyl polymer. Examples of vinyl polymers include homopolymers of hydroxyethyl methacrylate, hydroxypropyl methacrylate, dihydroxyethyl methacrylate, diethylene glycol methacrylate, triethylene glycol methacrylate, polyethylene glycol methacrylate, vinylpyrrolidone, acrylamide, dimethylacrylamide, glucoxyoxyethyl methacrylate, 3-sulfopropylmethacryloxyethyl dimethylammonium betaine, 2-methacryloyloxyethyl phosphorylcholine, and 1-carboxydimethylmethacryloyloxyethyl methane ammonium; and homopolymers of styrene, ethylene, propylene, propyl methacrylate, butyl methacrylate, ethylhexyl methacrylate, octadecyl methacrylate, and the like. Examples of the copolymers include random copolymers, graft copolymers, and block copolymers of hydrophobic monomers such as acrylate, benzyl methacrylate, and methoxyethyl methacrylate, and hydrophilic monomers such as hydroxyethyl methacrylate, hydroxypropyl methacrylate, dihydroxyethyl methacrylate, diethylene glycol methacrylate, triethylene glycol methacrylate, polyethylene glycol methacrylate, vinylpyrrolidone, acrylamide, dimethylacrylamide, glucoxyoxyethyl methacrylate, 3-sulfopropylmethacryloxyethyl dimethylammonium betaine, 2-methacryloyloxyethyl phosphorylcholine, and 1-carboxydimethylmethacryloyloxyethyl methane ammonium. Examples of the vinyl polymer include copolymers of cationic monomers such as dimethylaminoethyl methacrylate and diethylaminoethyl methacrylate, anionic monomers such as acrylic acid, methacrylic acid, vinyl sulfonic acid, sulfopropyl methacrylate and phosphooxyethyl methacrylate, and the above-mentioned hydrophobic monomers, and the like. The polymer may contain equal amounts of the anionic monomer and the cationic monomer so as to be electrically neutral.

[0026] [Electrically neutral] The water-insoluble hydrophilic polymer is preferably electrically neutral in order to prevent adsorption of proteins, which are solutes. In this embodiment, electrically neutral means that there is no charge in the molecule, or that there are equal amounts of cations and anions in the molecule.

[0027] Examples of the water-insoluble hydrophilic polymer include polysaccharides such as cellulose and its derivatives such as cellulose triacetate. In addition, the polysaccharides and their derivatives include those obtained by crosslinking hydroxyalkyl cellulose and the like. The water-insoluble hydrophilic polymer may be polyethylene glycol or a derivative thereof, or may be a block copolymer of ethylene glycol and the above-mentioned hydrophobic monomer, or a random or block copolymer of ethylene glycol and propylene glycol, ethylbenzyl glycol, etc. In addition, one or both ends of the polyethylene glycol and the above-mentioned copolymer may be substituted with a hydrophobic group to make them water-insoluble. Examples of the compound in which one or both ends of polyethylene glycol are substituted with a hydrophobic group include α,ω-dibenzylpolyethylene glycol and α,ω-didodecylpolyethylene glycol. In addition, it may be a copolymer of polyethylene glycol and a hydrophobic monomer such as dichlorodiphenylsulfone having halogen groups at both ends of the molecule. Examples of water-insoluble hydrophilic polymers include polyethylene terephthalate, polyethersulfone, etc. obtained by condensation polymerization, in which hydrogen atoms in the main chain of the polymer are substituted with hydrophilic groups, and the like are hydrophilized. Hydrophilized polyethylene terephthalate, polyethersulfone, etc. may have hydrogen atoms in the main chain substituted with anionic groups or cationic groups, or may have equal amounts of anionic groups and cationic groups. Bisphenol A type or novolac type epoxy resin in which the epoxy group is ring-opened, or vinyl polymer or polyethylene glycol or the like is introduced into the epoxy group may also be used. Silane-coupled ones may also be used. The water-insoluble hydrophilic polymers may be used alone or in combination of two or more kinds.

[0028] As the water-insoluble hydrophilic polymer, from the viewpoint of ease of production, homopolymers of hydroxyethyl methacrylate, hydroxypropyl methacrylate, dihydroxyethyl methacrylate; random copolymers of hydrophilic monomers such as 3-sulfopropyl methacryloxyethyl dimethylammonium betaine, 2-methacryloyloxyethyl phosphorylcholine, 1-carboxydimethyl methacryloyloxyethyl methane ammonium, and hydrophobic monomers such as butyl methacrylate, ethylhexyl methacrylate are preferred, and from the viewpoints of ease of selection of a solvent for the coating liquid when coating the water-insoluble hydrophilic polymer, dispersibility in the coating liquid, and operability, homopolymers of hydroxyethyl methacrylate, hydroxypropyl methacrylate; random copolymers of hydrophilic monomers such as 3-sulfopropyl methacryloxyethyl dimethylammonium betaine, 2-methacryloyloxyethyl phosphorylcholine, and hydrophobic monomers such as butyl methacrylate, ethylhexyl methacrylate are more preferred.

[0029] The water-soluble hydrophilic polymer may be, for example, a water-soluble hydrophilic polymer obtained by copolymerizing a monomer having an azide group in the side chain with a hydrophilic monomer such as 2-methacryloyloxyethyl phosphorylcholine on a base film of a hydrophobic polymer, and then heat-treating the base film to covalently bond the water-soluble hydrophilic polymer to the base film, thereby rendering the water-soluble hydrophilic polymer water-insoluble. Alternatively, a hydrophilic monomer such as 2-hydroxyalkyl acrylate may be graft-polymerized onto the base film of a hydrophobic polymer.

[0030] The porous membrane of this embodiment, or the base membrane of this embodiment, may be a membrane formed by blending a hydrophilic polymer and a hydrophobic polymer. The hydrophilic polymer used in the blend membrane formation is not particularly limited as long as it is compatible with the hydrophobic polymer in a good solvent, but the hydrophilic polymer is preferably polyvinylpyrrolidone or a copolymer containing vinylpyrrolidone. Specific examples of polyvinylpyrrolidone include LUVITEC (trade name) K60, K80, K85, and K90, which are commercially available from BASF, with LUVITEC (trade name) K80, K85, and K90 being preferred. As the copolymer containing vinylpyrrolidone, a copolymer of vinylpyrrolidone and vinyl acetate is preferred from the viewpoints of compatibility with hydrophobic polymers and suppression of interaction of proteins with the membrane surface. The copolymerization ratio of vinylpyrrolidone and vinyl acetate is preferably 6:4 to 9:1 from the viewpoints of protein adsorption onto the membrane surface and interaction with the polysulfone polymer within the membrane. Specific examples of the copolymer of vinylpyrrolidone and vinyl acetate include LUVISKOL (trade name) VA64 and VA73, which are commercially available from BASF. The hydrophilic polymers may be used alone or in combination of two or more kinds.

[0031] [Dense layer with low pore deformation] The inventors have found that it is extremely important to manufacture the outer surface of an inverted gradient structure membrane having a dense layer in the downstream filtration portion of the membrane as tension-free as possible in order to provide a porous membrane that has a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody and has excellent virus removal performance. In an inverted gradient structure membrane in which the outer surface of the porous membrane is a dense layer, or an inverted gradient structure membrane in which the dense layer is located near the outer surface, the dense layer has a structure that reflects the structure of the outer surface. In the manufacturing process of the porous membrane from when liquid-liquid phase separation is induced by contact between the membrane-forming solution and the non-solvent to when phase separation (solidification) is completed, the inventors have completed a dense layer with low pore deformation in the dense layer by manufacturing the outer surface of the porous membrane described below as tension-free as possible.

[0032] [Porosity in the dense layer near the outer surface of the porous membrane] In the porous membrane of this embodiment, the porosity of the dense layer near the outer surface is 35% or more and 45% or less. A low porosity means a high membrane resistance. If the porosity of the dense layer near the outer surface is less than 35%, it is difficult to obtain a virus removal membrane with a high filtration throughput of antibody-containing liquid due to hydrophobic interactions. From the principle of membrane production, it is difficult to produce a membrane with a porosity of more than 45% in the dense layer near the outer surface. A membrane with a porosity of 35% or more in the dense layer near the outer surface is realized by fixing both ends of the membrane in a wet state described below and performing a high-pressure hot water treatment with the thread bundle in a taut state and completely immersed in water.

[0033] [Long axis / short axis of the circumscribed rectangle of the hole in the dense layer near the outer surface of the porous membrane] In the porous membrane of this embodiment, the long diameter / short diameter of the hole circumscribing rectangle in the dense layer near the outer surface is preferably 1.00 or more and 1.45 or less. The large long diameter / short diameter of the hole circumscribing rectangle means that the hole is not circular, and the permeability of the filtration material is reduced. By manufacturing the outer surface of the porous membrane as tension-free as possible, it is possible to reduce the long diameter / short diameter of the hole circumscribing rectangle in the dense layer near the outer surface. If the dense layer near the outer surface can be manufactured completely tension-free, the hole circumscribing rectangle will be a hole circumscribing square, so the long diameter / short diameter of the hole circumscribing rectangle on the outer surface will not theoretically be less than 1.00. If the long diameter / short diameter of the hole circumscribing rectangle on the outer surface exceeds 1.45, it is difficult to obtain a virus removal membrane with a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody.

[0034] [Method of identifying the structure of a porous membrane] The porosity in the dense layer near the outer surface of the porous membrane and the pore deformation in the dense layer near the outer surface can be identified by the following method.

[0035] [Method of acquiring images of the dense layer near the outer surface of a porous membrane] When the porous membrane is a hollow fiber membrane, the outer surface is fixed to the observation sample stage of a scanning electron microscope (SEM) with carbon paste. The prepared sample is osmium coated using an osmium coater (HPC-30W, manufactured by Vacuum Device Co., Ltd.) with the applied voltage adjustment knob set to 4.5 and discharge time of 3 seconds, to prepare the observation sample. The observation sample is irradiated with an electron beam under the following conditions, and the viewing angle is adjusted so that the vertical direction of the image is parallel to the fiber length direction of the hollow fiber membrane. The contrast is adjusted using the auto function in a field of view consisting of only the skeleton resin and pores. The magnification that can explain the outer surface pore size distribution in which the largest pores in the vertical direction of the image are 5 to 60 and the largest pores in the horizontal direction of the image are 7 to 60 is set as the shooting magnification. A backscattered electron image is obtained that is free of structural distortion and abnormal contrast due to charge-up, and does not include the sample stage, carbon paste, or razor cut surface.

[0036] (SEM equipment conditions) SEM: Hitachi High-Technologies Corporation Scanning Electron Microscope SU7000 Probe current:Normal Acceleration voltage: 1 kV Working distance: 6mm Detector: MD detector (backscattered electron image) Image size: 1920 x 2560 pixels

[0037] For one type of hollow fiber membrane, three lots of hollow fiber membranes are used, and SEM images (a total of nine or more) are obtained from three or more fields of view without overlap for each lot.

[0038] [Calculation of porosity Co' near the outer surface of the porous membrane] The labels (letters and scale bar parts) of the electron microscope image are removed by trimming. This image is then filtered using a median filter with a 5x5 square kernel, and two non-zero thresholds are determined using the multi-Otsu method. The larger of these thresholds is used as the threshold, and the image is binarized with pixels below the threshold as black and other pixels as white. The brightness of white is 255 and that of black is 0. A closing process is performed once on the binarized image using a 2x2 square kernel to remove noise. With the total number of pixels in the entire image of the first analysis target image obtained as Ao and the number of black pixels as Bo, the porosity Co (%) of one SEM image is calculated using the following formula (1). Co = Bo x 100 / Ao (1)

[0039] For one type of porous membrane, SEM images of three fields of view (total of nine images) for each of three lots are used to calculate the porosity Co for a region of 0.2 to 0.5 μm from the outer surface side in one SEM image. The number average value of these porosities Co is defined as the porosity Co' near the outer surface of the porous membrane.

[0040] [Calculation of the major axis / minor axis M' of the circumscribing rectangle of the hole near the outer surface of the porous membrane] Independent white regions are extracted from the second image to be analyzed. For each extracted white region, the contour of each region is detected by extracting white pixels that have black adjacent pixels in either the up, down, left or right direction. As shown in Figure 1 (505: hole existing near the outer surface of the porous membrane), the rectangle with the smallest area that circumscribes this contour while taking rotation into consideration is determined as the circumscribing rectangle. Of the four sides of the circumscribing rectangle, the length of the short side is the minor axis K and the length of the long side is the major axis L, and M, which represents the major axis / minor axis of a certain contour, is given by the following formula (2). M=L / K (2)

[0041] For one type of porous membrane, three lots of three fields of view (total of nine images) or more are used to calculate the long diameter / short diameter M for a region 0.2 to 0.5 μm from the outer surface side in one SEM image. The number average value of these long diameter / short diameter M is defined as the long diameter / short diameter M' near the outer surface of the porous membrane.

[0042] [Cross-sectional structure of porous membrane] The porous membrane of the present embodiment preferably has a gradient structure in which the pore size changes continuously from the outer surface of the membrane to the liquid-contacting surface. Examples of the gradient structure include a sponge structure (normal gradient structure) in which the pore size is continuously smaller from the outer surface of the membrane to the liquid-contacting surface, a sponge structure (reverse gradient structure) in which the pore size is continuously smaller from the outer surface of the membrane to the smallest pore size layer and continuously larger from the smallest pore size layer to the liquid-contacting surface, and a sponge structure (reverse gradient structure) in which the pore size is continuously larger from the outer surface of the membrane to the liquid-contacting surface, but are not limited thereto. The cross-sectional structure of the porous membrane has a gradient structure in which the pore size changes continuously, which makes it possible to suppress clogging during filtration of a protein solution and to recover useful components such as antibodies with high efficiency. When considering the use of the porous membrane of this embodiment as a virus separation filtration membrane, a membrane with an inverted gradient structure having a minimum pore size layer (dense layer) at the downstream filtration site of the membrane is preferable. In this specification, the "dense layer" is a layer with an average pore size of 50 nm or less. Also, a layer with an average pore size of more than 50 nm is a "coarse layer". In this embodiment, the downstream filtration portion refers to the range from the downstream filtration surface corresponding to one membrane surface to 10% of the membrane thickness, and the upstream filtration portion corresponding to the other membrane surface refers to the range from the upstream filtration surface to 10% of the membrane thickness. For example, in a porous hollow fiber membrane, if a liquid is passed through the outer surface side, the range from the inner surface to 10% of the membrane thickness is the downstream filtration portion, and the range from the outer surface to 10% of the membrane thickness is the upstream filtration portion, and if a liquid is passed through the inner surface side, the range from the inner surface to 10% of the membrane thickness is the upstream filtration portion, and the range from the outer surface to 10% of the membrane thickness is the downstream filtration portion. In this embodiment, examples of the form of the porous membrane include a flat membrane, a hollow fiber membrane (hollow fiber-like membrane), and a tubular membrane.

[0043] The porous membrane of the present embodiment is preferably an inverted gradient structure membrane having a dense layer in the downstream filtration portion of the membrane, and has a gradient asymmetric structure in which the average pore size of the pores increases from the downstream filtration portion to the upstream filtration portion of the membrane, and the gradient index of the average pore size from the dense layer to the coarse layer is preferably 0.5 to 12.0. In this embodiment, the gradient index of the average pore size of the dense layer of the porous membrane and from the dense layer to the coarse layer is determined by photographing the membrane cross section with a scanning electron microscope (SEM). For example, the magnification is set to 50,000 times, and a field of view is set horizontally to the film thickness direction at any part of the membrane cross section. After imaging the set one field of view, the imaging field of view is moved horizontally to the film thickness direction, and the next field of view is imaged. This photographing operation is repeated to photograph the membrane cross section without gaps, and the obtained photographs are combined to obtain one membrane cross section photograph. In this cross section photograph, the average pore size in the range (one field of view) of (2 μm in the direction perpendicular to the film thickness direction) × (1 μm from the filtration downstream surface to the filtration upstream surface in the film thickness direction) is calculated every 1 μm from the filtration downstream surface to the filtration upstream surface.

[0044] The average pore size is calculated using a method that uses image analysis. Specifically, Image-pro plus manufactured by Media Cybernetics is used to perform binarization of the pores and the solid parts. The pores and solid parts are identified based on the brightness, and parts that cannot be identified and noise are corrected using a freehand tool. The edge parts that form the outline of the pores and the porous structure observed deep inside the pores are identified as pores. After binarization, the area value of each pore is assumed to be a perfect circle, and the pore size is calculated. This is performed for all pores, and the average pore size is calculated for each range of 1 μm x 2 μm. Note that pores that are interrupted at the edge of the field of view are also counted.

[0045] The gradient index of the average pore size from the dense layer to the coarse layer is calculated based on the field of view defined as the dense layer and the field of view of the coarse layer adjacent to the dense layer. The gradient index is calculated using the dense layer (first field) with an average pore size of 50 nm or less and the field of view of the coarse layer (second field) with an average pore size of more than 50 nm. Here, the first field and the second field are adjacent to each other. That is, when the average pore size increases from the downstream filtration portion of the membrane to the upstream filtration portion, the two fields in which the average pore size changes from 50 nm or less to more than 50 nm are the first field and the second field. Specifically, the gradient index of the average pore size from the dense layer with an average pore size of 50 nm or less to the coarse layer with an average pore size of more than 50 nm can be calculated by the following formula (1). Gradient index of average pore size from dense layer to coarse layer (nm / μm) = (average pore size (nm) of the coarse layer (second visual field) with an average pore size of more than 50 nm - average pore size (nm) of the dense layer (first visual field) with an average pore size of 50 nm or less) / 1 (μm) (1)

[0046] The virus removal mechanism in virus removal membranes is thought to be as follows: A solution containing viruses passes through a virus removal layer, which is made up of multiple layers of virus capture surfaces perpendicular to the permeation direction. There is always a distribution of pore sizes within these surfaces, and viruses are captured in pores that are smaller than the size of the virus. At this time, the virus capture rate at one surface is low, but by overlapping multiple layers of these surfaces, high virus removal performance is achieved. For example, even if the virus capture rate at one surface is 20%, by overlapping 50 layers of these surfaces, the overall virus capture rate will be 99.999%. A large number of viruses are captured in areas with an average pore size of 50 nm or less.

[0047] For example, the molecular size of antibodies, which are the main physiologically active substances to be filtered, is about 10 nm, while the size of parvoviruses is about 20 nm. The antibody solution, which is the filtration solution passed through the porous membrane, contains a larger amount of contaminants such as antibody aggregates than viruses. It is empirically known that even a slight increase in the amount of impurities in a protein solution leads to a significant decrease in flux. One of the causes of the decrease in flux over time is the clogging of the pores in the dense layer by impurities. In order to suppress the clogging of the pores in the dense layer by impurities, it is important to prevent the impurities from penetrating the dense layer, so it is preferable to capture the impurities in the gradient structure layer before the protein solution permeates the dense layer. In order to capture as many impurities as possible in the gradient-structure layer before passing through the dense layer, it is preferable to increase the impurity capture capacity of the gradient-structure layer excluding the dense layer. Since the permeation surface of the gradient-structure layer excluding the dense layer also has a pore size distribution, if the gradient of the average pore size from the dense layer to the gradient-structure layer is gentle, the surface that can capture impurities will increase, and the area that can capture impurities as a layer will increase. It is important to make the gradient of the average pore size from the dense layer to the coarse layer gentle in order to suppress a decrease in flux caused by impurities blocking the pores of the dense layer. In order to effectively capture impurities in the gradient structure layer immediately before the dense layer, the gradient index of the average pore size from the dense layer to the coarse layer is preferably 0.5 to 12.0, more preferably 2.0 to 12.0, and even more preferably 2.0 to 10.0.

[0048] Flux, which refers to the permeation rate of the filtrate solution, is governed by the rate at which the solution permeates the dense layer, which is the area of ​​the membrane with the smallest pore size. By preventing pore clogging in the dense layer, it is possible to prevent the decrease in flux over time during filtration. Prevention of the decrease in flux over time during filtration leads to efficient recovery of proteins.

[0049] In a virus removal membrane, viruses are mainly captured in the region with an average pore size of 50 nm or less, so in order to increase the virus capture capacity, it is preferable to thicken the dense layer. However, when the dense layer is thickened, the flux of the protein decreases. In order to recover proteins with high efficiency, the thickness of the dense layer is preferably 1 to 8 μm, and more preferably 2 to 6 μm.

[0050] In the present embodiment, the porous membrane is not particularly limited, but for example, when the porous membrane is a porous hollow fiber membrane having a hollow fiber shape, it can be manufactured as follows. The following describes an example in which a polysulfone-based polymer is used as the hydrophobic polymer. For example, polysulfone polymer, solvent, and non-solvent are mixed and dissolved, degassed, and used as the membrane-forming solution. The solution is extruded from the annular part and center of a double-tube nozzle (spinneret) together with an internal coagulation liquid, and is introduced into a coagulation bath through an idle section to form a membrane. The resulting membrane is washed with water, wound up, the liquid inside the hollow section is drained, heat-treated, and dried. It is then hydrophilized.

[0051] The solvent used for the membrane-forming solution may be any good solvent for polysulfone-based polymers, such as N-methyl-2-pyrrolidone (NMP), N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAc), dimethyl sulfoxide, ε-caprolactam, etc.; however, amide-based solvents such as NMP, DMF, and DMAc are preferred, and NMP is more preferred.

[0052] It is preferable to add a non-solvent to the film-forming solution. Examples of non-solvents used in the film-forming solution include glycerin, water, alcohols, and diol compounds, and diol compounds are preferred. Diol compounds are a general term for compounds having hydroxyl groups at both ends of the molecule. Examples of diol compounds include diethylene glycol (DEG), triethylene glycol (TriEG), tetraethylene glycol (TetraEG), and polyethylene glycol (PEG).

[0053] Although the detailed mechanism is unknown, adding a non-solvent to the membrane-forming solution increases the viscosity of the solution, which suppresses the diffusion rate of the solvent and non-solvent in the coagulation liquid, thereby controlling coagulation and making it easier to control the structure favorable for the porous membrane, which is suitable for forming the desired structure. The ratio of solvent / non-solvent in the film-forming solution is preferably 40 / 60 to 80 / 20 by mass.

[0054] The concentration of the polysulfone-based polymer in the membrane-forming solution is preferably 15 to 35% by mass, and more preferably 20 to 30% by mass, from the viewpoints of membrane strength and permeability.

[0055] The membrane-forming solution is obtained by dissolving a polysulfone polymer, a good solvent, and a non-solvent at a constant temperature while stirring. The temperature at this time is preferably 30 to 80°C, which is higher than room temperature. Compounds containing tertiary or lower nitrogen (NMP, DMF, DMAc) are oxidized in air, and the oxidation is more likely to proceed when heated, so the membrane-forming solution is preferably prepared under an inert gas atmosphere. Examples of inert gases include nitrogen and argon, and nitrogen is preferred from the viewpoint of production costs.

[0056] From the viewpoint of preventing thread breakage during spinning and suppressing the formation of macrovoids after membrane formation, it is preferable to degas the membrane-forming solution. The degassing process can be performed as follows. The pressure in a tank containing the completely dissolved film-forming solution is reduced to 2 kPa and the tank is left to stand for at least one hour. This operation is repeated seven times or more. To improve the efficiency of degassing, the solution may be stirred during degassing.

[0057] It is preferable to remove foreign matter from the membrane-forming solution before it is discharged from the spinneret. By removing foreign matter, it is possible to prevent thread breakage during spinning and control the structure of the membrane. In order to prevent foreign matter from entering through the packing of the membrane-forming solution tank, it is preferable to install a filter before the membrane-forming solution is discharged from the spinneret. Filters with different pore sizes may be installed in multiple stages, and are not particularly limited. For example, it is preferable to install a mesh filter with a pore size of 30 μm and a mesh filter with a pore size of 10 μm in that order from the side closest to the membrane-forming solution tank.

[0058] It is preferable to use the same components as those used in the membrane-forming stock solution and the coagulation solution as the internal coagulation solution used during membrane formation. For example, if NMP / TriEG is used as the solvent / non-solvent for the membrane-forming stock solution, and NMP / TriEG·water is used as the solvent / non-solvent for the coagulation solution, it is preferable that the internal coagulation solution is composed of NMP·TriEG·water. Increasing the amount of solvent in the internal coagulation liquid has the effect of slowing down the progress of coagulation and slowing down the formation of a membrane structure, while increasing the amount of non-solvent has the effect of slowing down the diffusion of the solution due to the thickening effect, slowing down the progress of coagulation and slowing down the formation of a membrane structure, and increasing the amount of water has the effect of accelerating the progress of coagulation. In order to allow the coagulation to proceed appropriately (not too quickly or too slowly), control the membrane structure, and obtain a porous hollow fiber membrane having a membrane structure preferred as a filtration membrane, it is preferable to use approximately equal amounts of the solvent and non-solvent, which are organic components in the internal coagulation liquid, and it is preferable that the ratio of the solvent / non-solvent, which are organic components in the internal coagulation liquid, is 35 / 65 to 65 / 35 by weight, and the ratio of the organic component / water is 70 / 30 to 100 / 0 by mass.

[0059] The spinneret temperature is preferably 25 to 50° C. in order to obtain an appropriate hole diameter. After being discharged from the spinneret, the membrane forming solution is introduced into the coagulation bath through the free-running section. The residence time in the free-running section is preferably 0.02 to 0.6 seconds. By making the residence time 0.02 seconds or more, sufficient coagulation can be achieved before introduction into the coagulation bath, and an appropriate hole diameter can be obtained. By making the residence time 0.6 seconds or less, excessive coagulation can be prevented, and precise control of the membrane structure in the coagulation bath can be made possible.

[0060] The inventors have completed a dense layer with low pore deformation by manufacturing the outer surface of the porous membrane as tension-free as possible during the porous membrane manufacturing process from when liquid-liquid phase separation is induced by contact of the membrane-forming solution with the non-solvent to when phase separation (solidification) is completed. In conventional methods, the membrane-forming solution passes through a filter and a spinneret, and is appropriately coagulated in the free-running section before being introduced into a coagulation bath. Liquid-liquid phase separation is induced in the membrane-forming solution by contact with the non-solvent in the internal coagulation liquid. When a membrane in an incomplete state of coagulation due to liquid-liquid phase separation is introduced into a general coagulation bath containing only the coagulation liquid, a stretching force (tension) acts on the membrane due to the bath resistance and frictional resistance caused by contact with the rolls in the coagulation bath, which tends to cause deformation of the pores in the dense layer on the outer surface or in the dense layer near the outer surface.

[0061] On the other hand, in the present invention, before the membrane is introduced into the coagulation bath, the outer surface of the membrane is brought into contact with a coagulation liquid (called "external coagulation liquid") moving in the same direction as the membrane's movement (i.e., parallel to the membrane's movement direction), thereby reducing the tension acting on the outer surface of the membrane, and thereby suppressing the deformation of the pores on the outer surface of the membrane. In this manner, the liquid exchange at the interface of the outer surface of the membrane is carried out very slowly, and coagulation proceeds slowly.

[0062] A specific example of the tensionless production is a method in which the membrane-forming raw material solution is discharged into a tube while an external coagulation liquid is made to flow in the tube in the same direction as the membrane-forming raw material solution is discharged. Note that there is an air gap between the tube and the spinneret that discharges the membrane-forming raw material solution.

[0063] The smaller the difference between the moving speed (linear speed) of the membrane-forming dope discharged from the spinneret and the moving speed (linear speed) of the external coagulating liquid, the more the tension during contact can be reduced. Therefore, the difference between the linear speed of the membrane-forming dope and the linear speed of the external coagulating liquid is preferably within ±12%, more preferably within ±10%, and even more preferably within ±5%. In this specification, when the difference is within ±12%, it is expressed as "same linear speed".

[0064] In order to suppress deformation of pores on the outer surface of the membrane, it is also preferable to slow down the spinning speed. The spinning speed is preferably 2 m / min or less, and from the viewpoint of productivity, it is preferably 0.1 m / min or more and 2 m / min or less.

[0065] The draft ratio ([take-off speed] / [linear extrusion speed of the film-forming solution]) is preferably 1.1 to 6, more preferably 1.1 to 4, and further preferably 1.1 to 2. When no stretching is applied between the take-off machine and the winder, the take-off speed is synonymous with the spinning speed.

[0066] It is preferable that the moving direction of the membrane (the discharge direction of the membrane-forming raw solution) and the moving direction of the external coagulation liquid are both vertical (that is, the direction of gravity).

[0067] The outer surface of the membrane is preferably in contact with the external coagulation liquid until phase separation (coagulation) is completed. The contact time is preferably 5 to 180 seconds, more preferably 10 to 150 seconds, and even more preferably 20 to 120 seconds.

[0068] A preferred production method is, for example, a method in which the spinning speed is 2 m / min or less, and the external coagulating liquid is brought into contact with the membrane-forming stock solution parallel to the discharge direction from the spinneret at the same linear speed as the membrane-forming stock solution discharged from the spinneret, from the time when liquid-liquid phase separation is induced by contact between the membrane-forming stock solution and the internal coagulating liquid until the phase separation is completed.

[0069] It is preferable that the external coagulation liquid used in the film formation has the same components as those used in the film formation stock solution and the internal coagulation liquid. Since the organic component has the effect of delaying coagulation, and water has the effect of accelerating coagulation, the composition of the external coagulation liquid is such that the solvent / non-solvent ratio for the organic component is 35 / 65 to 65 / 35 by mass, and the organic component / water ratio is preferably 90 / 10 to 50 / 50 by mass, and more preferably 60 / 40 to 40 / 60.

[0070] Here, the spinning speed (spinning speed) means a winding speed when there is no stretching operation during a series of steps in which the membrane-forming dope discharged from the spinneret together with the internal coagulating liquid passes through an air gap, and liquid-liquid phase separation is induced by contact between the membrane-forming dope discharged from the spinneret and the internal coagulating liquid, and the membrane that has passed through a coagulating bath is wound up, at the same linear speed as the membrane-forming dope discharged from the spinneret, until the phase separation is completed. In addition, if the air gap is surrounded by a cylindrical tube or the like and a gas having a constant temperature and humidity is flowed through the air gap at a constant flow rate, it is possible to produce a hollow fiber membrane in a more stable state.

[0071] In general, when the concentration of the membrane-forming raw material in the raw solution is lowered, the temperature of the raw solution is increased, the concentration of the good solvent in the internal coagulation liquid is lowered, or the temperature of the internal coagulation liquid is increased, the pore size becomes larger, the flux increases, but the LRV decreases. In addition, when the coagulation force is weakened during membrane formation, for example, when a poor solvent with a weak coagulation force is added to the raw solution, or when a good solvent is added to the external coagulation liquid, the dense layer becomes thicker, the flux decreases, but the LRV increases. In this way, by optimizing various membrane formation conditions and forming the membrane without tension, it is possible to produce a virus removal membrane with a membrane structure that achieves both filtration and virus removal.

[0072] The virus clearance of the porous membrane is preferably an LRV of at least 5. As the parvovirus, one that is similar to a virus that is mixed in during the actual purification process and is preferably minute virus of mice (MVM) from the viewpoint of ease of operation.

[0073] The hollow fiber membrane is removed from the coagulation bath and washed with warm water. In the water washing step, it is preferable to completely remove the residual solvent and non-solvent. If the hollow fiber membrane is dried while still containing the solvent, the solvent may be concentrated in the membrane during drying, causing the polysulfone polymer to dissolve or swell, which may cause a change in the membrane structure. In order to increase the diffusion rate of the solvent and non-solvent to be removed and the hydrophilic polymer not fixed to the membrane, and to increase the efficiency of the washing, the temperature of the hot water is preferably 50°C or higher. It is preferable to use a Nelson roller for the washing process. In order to thoroughly wash the membrane with water, the residence time of the hollow fiber membrane in the washing bath is preferably 80 to 300 seconds. The longer the washing step for removing unnecessary components, the better, but from the viewpoint of production efficiency, it is appropriate to keep the residence time at 300 seconds or less.

[0074] The hollow fiber membrane is taken up from the water washing bath and wound into a skein by a winding machine. If the hollow fiber membrane is wound up in air, it gradually dries and shrinks slightly. The degree of shrinkage of the membrane differs between the early and late stages of winding, resulting in different membrane structures, which causes non-uniformity in the hollow fiber membrane obtained in the production process. To obtain a uniform membrane, it is preferable to wind the hollow fiber membrane in water.

[0075] The hollow fiber membrane wound on the reel is cut at both ends so that the length is 60 cm or less, bundled, and both ends are wrapped with film. The film-wrapped part is tied with a band and held on a support so as not to slacken. The held hollow fiber membrane is then washed in a hot water treatment process after a water washing process in which water is passed through the inside of the hollow fiber. The fixed hollow fiber membrane is then washed in a hot water treatment process after a water washing process in which water is passed through the inside of the hollow fiber. In the hollow fiber membrane wound on a reel, a cloudy liquid containing suspended nanometer to micrometer sized polysulfone polymer particles remains. If the hollow fiber membrane is dried without removing the cloudy liquid, the polysulfone polymer particles may clog the pores of the hollow fiber membrane, resulting in a decrease in membrane performance. Therefore, it is preferable to remove the cloudy liquid in the hollow portion. In the hot water treatment step, fine particles and the like that could not be completely removed in the water washing step are efficiently removed. The temperature of the hot water is preferably 50 to 100° C. A hot water temperature of 50° C. or higher is preferable in terms of increasing the washing efficiency. The washing time is preferably 30 to 120 minutes. It is preferable to change the hot water several times during washing.

[0076] In this embodiment, the wound hollow fiber membrane is preferably subjected to high-pressure hot water treatment. Specifically, the fiber bundle is held by a support so as not to slacken in a wet state with a length of 60 cm or less, and the bands at both ends are held by a support in a state in which the fiber bundle is taut so that a force of 0.01 to 0.05 N is applied in the fiber length direction. This fiber bundle is preferably completely immersed in water, placed in a high-pressure steam sterilizer, and kept at 120°C or higher for 2 to 6 hours. By performing high-pressure hot water treatment in a taut state of the fiber bundle, not only is the shrinkage of the hollow fiber suppressed, but also, although the detailed mechanism is unknown, traces of solvent and non-solvent remaining in the hollow fiber membrane and hydrophilic polymers not fixed to the membrane are completely removed, and the entanglement and existence state of polysulfone-based polymers in the dense layer region are optimized, and the porosity near the outer surface is also optimized. From the viewpoint of production efficiency, the treatment time is preferably 6 hours or less.

[0077] In the present invention, by appropriately setting the difference between the movement speed of the membrane-forming stock solution discharged from the spinneret and the movement speed of the external coagulation liquid, the spinning speed, and the draft ratio, the tension applied to the membrane from the time the membrane-forming stock solution is discharged from the spinneret to the completion of coagulation is reduced, thereby suppressing pore deformation in the dense layer on the outer surface and in the dense layer near the outer surface. Furthermore, by performing high-pressure hot water treatment with the yarn bundle in a taut state, the porosity near the outer surface is optimized, and a virus removal membrane with a high filtration throughput of antibody-containing liquid due to hydrophobic interactions can be produced.

[0078] The porous hollow fiber membrane of this embodiment is preferably vacuum-dried from a wet state with a wet bundle of fibers of 60 cm or less stretched, after a step of heat-treating the membrane at 120° C. or higher while the wet bundle of fibers of 60 cm or less is stretched. Although there are other drying methods such as air drying and hot air drying, it is preferable to dry the membrane with a wet bundle of fibers of 60 cm or less stretched, so that the membrane does not shrink during drying. From the viewpoint of ease of filter processing, the inner diameter of the porous membrane is preferably 200 to 400 μm, and the membrane thickness is preferably 30 to 80 μm.

[0079] The base film (porous film before coating) undergoes a coating step to become the porous film of this embodiment. For example, when the hydrophilization treatment is performed by coating, the coating step includes a step of immersing the base membrane in a coating liquid, a step of draining the immersed base membrane, and a step of drying the drained base membrane. In the immersion step, the substrate membrane is immersed in a hydrophilic polymer solution. The solvent of the coating solution is not particularly limited as long as it is a good solvent for the hydrophilic polymer and a poor solvent for the polysulfone-based polymer, but alcohol is preferred. The concentration of the water-insoluble hydrophilic polymer in the coating solution is preferably 1.0% by mass or more in order to sufficiently coat the pore surfaces of the base membrane with the hydrophilic polymer and suppress a decrease in flux over time due to protein adsorption during filtration, and is preferably 10.0% by mass or less in order to coat the pore surfaces to an appropriate thickness and prevent the pore size from becoming too small, which would result in a decrease in flux. The immersion time of the substrate membrane in the coating liquid is preferably 8 to 24 hours.

[0080] In the dehydration step, excess coating liquid adhering to the hollow and outer periphery of the base membrane immersed in the coating liquid for a predetermined time is dehydrated by centrifugation. From the viewpoint of preventing adhesion of the membranes to each other after drying due to the remaining hydrophilic polymer, it is preferable to set the centrifugal force during centrifugation to 10 G or more and the centrifugation time to 30 minutes or more. EXAMPLES

[0081] The present embodiment will be described in detail below with reference to examples, but the present invention is not limited to the following examples. The measurement methods shown in the examples are as follows. The porosity and the major axis / minor axis of the pore circumscribing rectangle in the dense layer near the outer surface, as well as the gradient index of the average pore size from the dense layer to the coarse layer were measured by the above-mentioned methods.

[0082] (1) Measurement of inner diameter and film thickness The inner diameter of the porous hollow fiber membrane was determined by photographing the perpendicular cut surface of the membrane with a stereomicroscope. The outer diameter was determined in the same manner as the inner diameter, and the membrane thickness was calculated by (outer diameter-inner diameter) / 2. The membrane area was calculated from the inner diameter and the effective length of the hollow fiber membrane.

[0083] (2) Measurement of pure water permeability Effective membrane area is 3.3 cm 2 The amount of pure water filtered at 25° C. was measured by dead-end filtration at a constant pressure of 1.0 bar using a filter assembled so as to obtain the amount of water permeable therethrough, and the amount of water permeable was calculated from the filtration time.

[0084] (3) Protein filtration test Effective membrane area is 3.3 cm 2 The assembled filter was subjected to high-pressure steam sterilization at 122°C for 60 minutes. The cumulative filtration volume of protein was determined by the following experiment. A solution of 100 mM acetic acid-sodium hydroxide buffer, 200 mM sodium chloride, pH 5.5, was filtered at a constant pressure of 2.0 bar at a temperature of 25°C to obtain a concentration of 15 mg / mL. The cumulative protein recovery volume was calculated from the filtrate recovery volume, the protein concentration of the filtrate, and the membrane area of ​​the filter. The protein used for filtration was a formulation purchased for research purposes.

[0085] (4) Viral clearance measurement (3) The solution prepared in the protein filtration test was spiked with 0.5% by volume of minute virus of mice (MVM) solution to prepare the filtrate. The prepared filtrate was filtered at the dead end for 180 minutes at a constant pressure of 2.0 bar. The titer (TCID50 value) of the filtrate was measured by virus assay. The virus clearance of MVM was calculated as LRV = Log(TCID50) / mL(filtrate) - Log(TCID50) / mL(filtrate). In this measurement, a LRV of 5 or more was considered to be a high virus removal ability.

[0086] (5) Elution evaluation The filter prepared in the same manner as in (3) was used to filter 100 mL of pure water at 25°C by constant pressure dead-end filtration at 2.0 bar, and the filtrate was collected and concentrated. The carbon amount was measured using the concentrated liquid obtained with a total organic carbon meter TOC-L (Shimadzu Corporation), and the elution rate from the membrane was calculated.

[0087] (6) Measurement of antibody hydrophobic interaction (HIC) The HPLC system used was an ACQUITY UPLC H-Class Bio system (Waters), the column used was an ACQUITY TSKgel Butyl-NPR Column (Waters), and the detector used was an ultraviolet-visible detector (280 nm). The eluents used were 2M ammonium sulfate aqueous solution, 0.04M phosphate buffer (pH 7.0), and ultrapure water. The HIC value was determined as the retention time ratio when the retention time of Venoglobulin IH 5% intravenous injection, commercially available from Mitsubishi Tanabe Pharmaceuticals, was set to 1.

[0088] (7) Thickness of dense layer The cross section of the hollow fiber was photographed using a scanning electron microscope (SEM) with an acceleration voltage of 1 kV and a magnification of 50,000 times, with the field of view set horizontally to the membrane thickness direction at any part of the cross section of the hollow fiber. After photographing one set field of view, the field of view was moved horizontally to the membrane thickness direction, and the next field of view was photographed. This photographing operation was repeated to photograph the membrane cross section without any gaps, and the obtained photographs were combined to obtain a single membrane cross section photograph. In this cross section photograph, the average pore size was calculated in the range of (2 μm in the circumferential direction of the membrane) × (1 μm from the outer surface to the inner surface). The average pore size was calculated using a method that uses image analysis. Using Image-pro plus manufactured by Media Cybernetics, the pores and the solid parts were identified based on the brightness. The parts that could not be identified and noise were corrected with a freehand tool, and the edge parts that form the outline of the pores and the porous structure observed deep inside the pores were identified as pores. After binarization, the area value of each pore was assumed to be a perfect circle, and the diameter of the pores was calculated with two significant digits. This was performed for all pores, and the average pore size was calculated for each range of 1 μm × 2 μm. It was decided to count the pores that were interrupted at the edge of the field of view. The field of view where the average pore size was 50 nm or less was defined as the dense layer, and the thickness of the dense layer was calculated as "the number of images showing an average pore size of 50 nm or less x 1 μm."

[0089] [Example 1] 24 parts by mass of PES (ULTRASON (registered trademark) E6020P manufactured by BASF), 36 parts by mass of NMP (manufactured by Kishida Chemical Co., Ltd.), and 40 parts by mass of TriEG (manufactured by Kanto Chemical Co., Ltd.) were mixed at 35°C, and the mixture was subjected to degassing under reduced pressure at 2 kPa seven times to obtain a solution for membrane production. This membrane-forming stock solution was kept at 35 ° C., and discharged from a spinneret (double annular nozzle, nozzle temperature 35 ° C., temperature of the membrane-forming stock solution at the nozzle 35 ° C., temperature of the internal coagulation solution 35 ° C.) together with 75 parts by mass of NMP and 25 parts by mass of water (water content 25 wt%), and passed through a sealed 30 mm air gap. At the same linear speed as the membrane-forming stock solution discharged from the spinneret, an external coagulation solution (temperature 20 ° C.) consisting of 25 parts by mass of NMP and 75 parts by mass of water was contacted with the membrane-forming stock solution for 2 m parallel to the discharge direction from the spinneret (traveled 2 m with the external coagulation solution in a tube with a diameter of 1.0 cm), and then introduced into a coagulation bath containing a coagulation solution consisting of 25 parts by mass of NMP and 75 parts by mass of water at 20 ° C. The spinning speed was 1.5 m / min. It was confirmed that phase separation was completed by contacting the membrane-forming stock solution and the external coagulation solution for 2 m parallel to the discharge direction from the spinneret. The draft ratio (the ratio of the spinning speed to the linear velocity of the membrane-forming solution discharged from the spinneret) was set to 2. The membrane drawn out from the coagulation bath was made to run on a Nelson roll through a water washing tank set at 55°C, and then wound up on a reel in water. The wound membrane was cut at both ends of the skein, and the 45 cm long wet membrane was bundled, wrapped at both ends with film, tied with a band, and held to a support to prevent loosening, while water was passed through the inside of the hollow fiber for 15 minutes. Next, both ends of the 45 cm long wet membrane were held to a support while being stretched with a force of 0.02 N in the direction of the fiber length, and treated with high-pressure hot water at 128°C for 3 hours. The 45 cm long wet membrane was then vacuum-dried from the wet state while both ends were fixed, to obtain a hollow fiber-shaped base membrane. The obtained hollow fiber-shaped base membrane was immersed in a coating solution of 2.5 parts by mass of polyhydroxyethyl methacrylate (produced using hydroxyethyl methacrylate (manufactured by Kanto Chemical Co., Ltd.)) having a weight average molecular weight of 80 kDa and 97.5 parts by mass of methanol for 24 hours, and then centrifuged at 12.5 G for 30 minutes to remove the liquid. After centrifugal dewatering, the membrane was vacuum dried for 18 hours to obtain a hollow fiber-shaped porous membrane. A monoclonal antibody with an HIC value of 1.01 and an isoelectric point of 6.5 was used for the protein filtration test. The protein throughput satisfied B=-62.59A+84.68±2.5 (1.01≦A≦1.25). The performance of the obtained porous membrane is shown in Table 1 below. It was confirmed that the membrane has a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody, and is a virus removal membrane.

[0090] [Example 2] The protein filtration test was carried out in the same manner as in Example 1, except that a monoclonal antibody with an HIC value of 1.16 and an isoelectric point of 7.1 was used. The protein processing amount satisfied B=-62.59A+84.68±2.5 (1.01≦A≦1.25). The performance of the porous membrane is shown in Table 1 below. It was confirmed that the virus removal membrane has a high filtration processing amount of the antibody-containing liquid due to the hydrophobic interaction of the antibody.

[0091] [Example 3] The protein filtration test was carried out in the same manner as in Example 1, except that a monoclonal antibody with an HIC value of 1.25 and an isoelectric point of 7.0 was used. The protein processing amount satisfied B=-62.59A+84.68±2.5 (1.01≦A≦1.25). The performance of the porous membrane is shown in Table 1 below. It was confirmed that the virus removal membrane has a high filtration processing amount of the antibody-containing liquid due to the hydrophobic interaction of the antibody.

[0092] [Example 4] The same procedure as in Example 1 was repeated, except that the external coagulation liquid temperature and the external coagulation liquid temperature were set to 25° C. It was confirmed that phase separation was completed by contacting the membrane-forming solution and the external coagulation liquid for 2 m parallel to the extrusion direction from the spinneret. A monoclonal antibody with an HIC value of 1.01 and an isoelectric point of 6.5 was used for protein filtration studies. The protein throughput satisfied B = -62.59A + 84.68 ± 2.5 (1.01 ≤ A ≤ 1.25). The performance of the obtained porous membrane is shown in Table 1 below. It was confirmed that the membrane has a high filtration throughput of antibody-containing liquid due to hydrophobic interactions of the antibody, and is a virus removal membrane.

[0093] [Example 5] The protein filtration test was carried out in the same manner as in Example 4, except that a monoclonal antibody with an HIC value of 1.16 and an isoelectric point of 7.1 was used. The protein processing amount satisfied B=-62.59A+84.68±2.5 (1.01≦A≦1.25). The performance of the porous membrane is shown in Table 1 below. It was confirmed that the filtration processing amount of the antibody-containing liquid due to the hydrophobic interaction of the antibody is high, and that this is a virus removal membrane.

[0094] [Example 6] The protein filtration test was carried out in the same manner as in Example 4, except that a monoclonal antibody with an HIC value of 1.25 and an isoelectric point of 7.0 was used. The protein processing amount satisfied B=-62.59A+84.68±2.5 (1.01≦A≦1.25). The performance of the porous membrane is shown in Table 1 below. It was confirmed that the virus removal membrane has a high filtration processing amount of the antibody-containing liquid due to the hydrophobic interaction of the antibody.

[0095] [Example 7] The substrate membrane obtained in Example 1 was irradiated with gamma rays at 25 kGy, and then immersed in a solution of 7 parts by mass of 2-hydroxypropyl acrylate (Tokyo Chemical Industry Co., Ltd.), 25 parts by mass of t-butanol (Kanto Chemical Co., Ltd.), and 68 parts by mass of water at 50° C. to carry out graft polymerization for 1 hour. After the graft polymerization, the membrane was washed with t-butanol at 50° C. to remove unreacted materials, and then vacuum dried for 18 hours to obtain a hollow fiber-shaped porous membrane. A monoclonal antibody with an HIC value of 1.01 and an isoelectric point of 6.5 was used for protein filtration studies. The protein throughput satisfied B = -62.59A + 84.68 ± 2.5 (1.01 ≤ A ≤ 1.25). The performance of the obtained porous membrane is shown in Table 1 below. It was confirmed that the membrane has a high filtration throughput of antibody-containing liquid due to hydrophobic interactions of the antibody, and is a virus removal membrane.

[0096] [Example 8] The membrane-forming stock solution was kept at 40 ° C., and discharged from a spinneret (double annular nozzle, nozzle temperature 40 ° C., temperature of the membrane-forming stock solution at the nozzle 40 ° C., temperature of the internal coagulation solution 40 ° C.) together with 74 parts by mass of NMP and 26 parts by mass of water (water content 26 wt%), and passed through a sealed 30 mm air gap. At the same linear speed as the membrane-forming stock solution discharged from the spinneret, an external coagulation solution (temperature 18 ° C.) consisting of 45 parts by mass of NMP and 55 parts by mass of water was contacted with the membrane-forming stock solution for 2 m parallel to the discharge direction from the spinneret (traveled 2 m with the external coagulation solution in a tube with a diameter of 1.0 cm), and then introduced into a coagulation bath containing a coagulation solution consisting of 45 parts by mass of NMP and 55 parts by mass of water at 18 ° C., in the same manner as in Example 1. It was confirmed that phase separation was completed by contacting the membrane-forming stock solution and the external coagulation solution for 2 m parallel to the discharge direction from the spinneret. A monoclonal antibody with an HIC value of 1.16 and an isoelectric point of 7.1 was used for protein filtration studies. The protein throughput satisfied B = -62.59A + 84.68 ± 2.5 (1.01 ≤ A ≤ 1.25). The performance of the obtained porous membrane is shown in Table 1 below. It was confirmed that the membrane has a high filtration throughput of antibody-containing liquid due to hydrophobic interactions of the antibody, and is a virus removal membrane.

[0097] [Example 9] The protein filtration test was carried out in the same manner as in Example 8, except that a monoclonal antibody with an HIC value of 1.25 and an isoelectric point of 7.0 was used. The protein processing amount satisfied B=-62.59A+84.68±2.5 (1.01≦A≦1.25). The performance of the porous membrane is shown in Table 1 below. It was confirmed that the filtration processing amount of the antibody-containing liquid due to the hydrophobic interaction of the antibody is high, and that this is a virus removal membrane.

[0098] [Comparative Example 1] The same procedure as in Example 1 was repeated, except that the external coagulation liquid temperature and the coagulation liquid temperature were 25° C., the spinning speed was 5 m / min, and the draft ratio was 2. Since the long axis / short axis ratio of the hole circumscribing rectangle near the outer surface increased, the protein processing amount was 18.5 kg, which did not satisfy B=-62.59A+84.68±2.5 (1.01≦A≦1.25).

[0099] [Comparative Example 2] The same procedure as in Example 1 was repeated except that the spinning speed was 20 m / min and the ratio of the spinning speed to the linear velocity of the membrane-forming solution extruded from the spinneret was 10. A monoclonal antibody with an HIC value of 1.01 and an isoelectric point of 6.5 was used for protein filtration studies. The performance of the obtained porous membrane is shown in the following Table 1. The vicinity of the outer surface of the porous membrane and the dense layer to the coarse layer did not have an appropriate structure, so the virus removal performance was reduced.

[0100] [Comparative Example 3] The protein filtration test was carried out in the same manner as in Comparative Example 2, except that a monoclonal antibody having an HIC value of 1.16 and an isoelectric point of 7.1 was used. The performance of the obtained porous membrane is shown in the following Table 1. The vicinity of the outer surface of the porous membrane and the dense layer to the coarse layer did not have an appropriate structure, so the virus removal performance was reduced.

[0101] [Comparative Example 4] The protein filtration test was carried out in the same manner as in Comparative Example 2, except that a monoclonal antibody having an HIC value of 1.25 and an isoelectric point of 7.0 was used. The performance of the obtained porous membrane is shown in the following Table 1. The vicinity of the outer surface of the porous membrane and the dense layer to the coarse layer did not have an appropriate structure, so the virus removal performance was reduced.

[0102] [Comparative Example 5] 26 parts by mass of PES (ULTRASON (registered trademark) E6020P manufactured by BASF), 32 parts by mass of NMP (manufactured by Kishida Chemical Co., Ltd.), 32 parts by mass of TriEG (manufactured by Kanto Chemical Co., Ltd.), and 10 parts by mass of a copolymer of vinylpyrrolidone and vinyl acetate (Luviskol (registered trademark) VA64 manufactured by BASF, hereinafter referred to as "VA64") were mixed at 50°C, and the solution was subjected to degassing under reduced pressure at 2 kPa seven times to prepare a film-forming stock solution. This membrane-forming solution was kept at 50 ° C., and discharged from a spinneret (double annular nozzle, nozzle temperature 50 ° C., temperature of the membrane-forming solution at the nozzle 50 ° C., temperature of the internal coagulation solution 50 ° C.) together with 42.8 parts by mass of NMP, 52.2 parts by mass of TriEG, and 5 parts by mass of water (water content 5 wt%), and passed through a sealed 30 mm air gap. At the same linear speed as the membrane-forming solution discharged from the spinneret, an external coagulation solution (temperature 20 ° C.) consisting of 38.9 parts by mass of NMP, 46.7 parts by mass of TriEG, and 15 parts by mass of water was contacted with the membrane-forming solution for 2 m parallel to the discharge direction from the spinneret (traveled 2 m with the external coagulation solution in a tube with a diameter of 1.0 cm), and then introduced into a coagulation bath containing a coagulation solution consisting of 38.9 parts by mass of NMP, 46.7 parts by mass of TriEG, and 15 parts by mass of water at 20 ° C. The spinning speed was 5 m / min. It was confirmed that phase separation was completed by contacting the membrane-forming solution and the external coagulation solution for 2 m in parallel with the discharge direction from the spinneret. The ratio of the spinning speed to the linear discharge speed of the membrane-forming solution from the spinneret was set to 2. The membrane drawn out from the coagulation bath was run on a Nelson roll through a water washing tank set at 55°C, and then wound up in water using a reel. Subsequent treatments were performed in the same manner as in Example 1. A monoclonal antibody with an HIC value of 1.01 and an isoelectric point of 6.5 was used for protein filtration studies. The performance of the obtained porous membrane is shown in the following Table 1. Because the dense layer was thick, the protein processing amount was 5 kg, which did not satisfy B=-62.59A+84.68±2.5 (1.01≦A≦1.25).

[0103] [Comparative Example 6] The protein filtration test was carried out in the same manner as in Comparative Example 5, except that a monoclonal antibody having an HIC value of 1.16 and an isoelectric point of 7.1 was used. The performance of the obtained porous membrane is shown in the following Table 1. Because the dense layer was thick, the protein processing amount was 4.0 kg, which did not satisfy B=-62.59A+84.68±2.5 (1.01≦A≦1.25).

[0104] [Comparative Example 7] The protein filtration test was carried out in the same manner as in Comparative Example 5, except that a monoclonal antibody having an HIC value of 1.25 and an isoelectric point of 7.0 was used. The performance of the obtained porous membrane is shown in the following Table 1. Because the dense layer was thick, the protein processing amount was 3.5 kg, which did not satisfy B=-62.59A+84.68±2.5 (1.01≦A≦1.25).

[0105] [Comparative Example 8] Except for the fact that the yarn bundle was not kept taut and that the high-pressure hot water treatment was performed, the same procedure was followed as in Example 1. Since the porosity in the vicinity of the outer surface decreased, the relationship B=-62.59A+84.68±2.5 (1.01≦A≦1.25) was not satisfied.

[0106] [Table 1] [Industrial Applicability]

[0107] INDUSTRIAL APPLICABILITY The porous membrane according to the present invention is suitable for industrial use because it has a high filtration throughput of an antibody-containing liquid due to hydrophobic interactions of the antibody and has excellent virus removal performance.

Claims

1. A porous membrane containing a hydrophobic polymer and a hydrophilic polymer, The porosity of the dense layer near the outer surface is 35% or more and 45% or less, the ratio of the major axis / minor axis of a circumscribing rectangle of a hole in the dense layer near the outer surface is 1.00 or more and 1.45 or less; The dense layer has a thickness of 1 to 8 μm, A solution at 25°C adjusted with a buffer solution to give an antibody concentration of 15 mg / mL is filtered through the porous membrane at an effective filtration pressure of 196 kPa for 3 hours, and the porous membrane satisfies the relationship B = -62.59A + 84.68 ± 2.5 (1.01 ≦ A ≦ 1.25), where A is the hydrophobic interaction of the antibody and B is the amount of the antibody-containing solution that is filtered.

2. The porous membrane according to claim 1 , wherein the hydrophilic polymer is an electrically neutral, water-insoluble hydrophilic polymer.

3. The porous membrane according to claim 1 , wherein the hydrophobic polymer is a polysulfone-based polymer.

4. The porous membrane according to claim 2 , wherein the water-insoluble hydrophilic polymer is a vinyl polymer.

5. The porous membrane according to claim 1 , wherein the porous membrane has a gradient structure in which the pore size changes continuously from the outer surface of the porous membrane toward the liquid-contacting surface.

6. 6. The porous membrane according to claim 1, wherein the gradient index of the average pore size from the dense layer to the coarse layer is 0.5 to 12.

0.

7. The porous membrane of claim 1 or 5, wherein the porous membrane is an ultrafiltration membrane.

8. The porous membrane according to claim 1 or 5, which is a virus removal membrane.

9. The porous membrane according to claim 1 or 5, which is a hollow fiber membrane or a tubular membrane.

10. A filter comprising the porous membrane according to claim 1 or 5.

Citation Information

Patent Citations

  • Error detection system

    JP1979003444A

  • Image pickup device

    JP1988067977A

  • Method and device for ultrasonic flaw detection

    JP1988085444A

  • Wide angle photographing lens

    JP1989033513A

  • Filter membrane for physiologically active substance solution

    JP4024041B2